TCT-623 12 months outcomes of a Non-inferiority Randomized Clinical Trial comparing the efficacy and safety of Angiolite vs Xience in patients with PCI indication

José Moreu Burgos,Armando Pérez de Prado,Bruno Diez Garcia,Raul Moreno,José Antonio Acevedo Díaz,Eduardo Pinar Bermudez

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2018）

引用 0|浏览12

暂无评分

摘要

Xience cobalt chromium everolimus-eluting stent (CoCr-EES) is considered as the gold standard. Recently, the Angiolite cobalt chromium sirolimus-eluting stent (CoCr-SES) has been introduced to the market. To prove its non-inferiority in terms of efficacy and safety vs Xience, we conducted a

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要